General Hospital Of Shenyang Military Region

This study aims to settle a medical debate about whether patients with advanced liver disease (cirrhosis) should routinely take acid-suppression drugs after a preventive procedure for swollen veins in their esophagus. Researchers will enroll 210 patients and randomly assign half …

This study is testing whether giving a second dose of a clot-busting drug helps stroke patients who don't show improvement after the first standard dose. Researchers will enroll 120 adults who had a stroke within 3 hours and received the initial medication but didn't get better. …

This study aims to find out which of two existing drugs works better for liver cirrhosis patients who have a dangerous stomach bleed and sudden kidney injury. Researchers will compare terlipressin and somatostatin in 64 patients to see which one is more effective at reversing the…

This study is testing if giving a second dose of a clot-busting drug (tenecteplase) helps stroke patients who don't show significant improvement one hour after the first standard dose. It will involve 198 adults who have had an ischemic stroke caused by a blocked blood vessel in …